ABC Compounding Company Inc

CLOSEOUT LETTER ABC Compounding Company Inc MARCS-CMS 576953 — May 02, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Drugs Recipient: Recipient Name Jon Craytor ABC Compounding Company Inc 2600 Dogwood Dr. NE Conyers , GA 30013 United States Issuing Office: Center for Drug Evaluation and Research United States Dear Mr. Craytor: The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter #1398, issued on April 18, 2019. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter and corrected the data deficiencies. Future FDA regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and to continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Maria Rossana R. Cook Director Office of Program and Regulatory Operations Office of Compliance Center for Drug Evaluation and Research Content current as of: 05/07/2019 Regulated Product(s) Drugs